SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Date of Report (Date of Earliest Event Reported): August 1, 2003
| INVITROGEN CORPORATION |
|
(Exact name of registrant as specified in its charter)
|
| Delaware | 0-25317 | 33-0373077 | ||
(State or other jurisdiction of incorporation) |
(Commission File No.)
|
(IRS Employer Identification No.) |
| 1600 Faraday Avenue, Carlsbad, CA | 92008 | |
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (760) 603-7200
| Not Applicable |
|
(Former name or former address, if changed since last report)
|
| Item 5. OTHER EVENTS | ||||||||
| Item 7. FINANCIAL STATEMENTS AND EXHIBITS. | ||||||||
| SIGNATURE | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. OTHER EVENTS
On August 1, 2003, Invitrogen Corporation (the “Company”) issued a press release regarding the closing of its offering of $325 million aggregate principal amount of 2% Convertible Senior Notes due 2023 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Attached as Exhibit 99.1 is the press release of the Company regarding the closing of the offering of the Convertible Senior Notes. Exhibit 99.1 is incorporated by reference under this Item 5.
Item 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
| Exhibit | Description | ||
99.1 |
Invitrogen Corporation press release dated August 1, 2003 regarding the closing of the offering of $325 million of convertible senior notes. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its
behalf by the
undersigned hereunto duly authorized.
| Invitrogen Corporation | ||||
Date: August 5, 2003 |
By: | /s/ C. Eric Winzer | ||
| C. Eric Winzer Chief Financial Officer |
||||
2
| EXHIBIT INDEX | ||
| Exhibit | Description | |
99.1 |
Invitrogen Corporation press release dated August 1, 2003
regarding the offering of convertible senior notes. |
|
3